| Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyrindine (MPTP) and oxidative stress RH Kim, PD Smith, H Aleyasin, S Hayley, MP Mount, S Pownall, ... Proceedings of the National Academy of Sciences 102 (14), 5215-5220, 2005 | 878 | 2005 |
| NMDA receptors in clinical neurology: excitatory times ahead LV Kalia, SK Kalia, MW Salter The Lancet Neurology 7 (8), 742-755, 2008 | 552 | 2008 |
| α‐Synuclein oligomers and clinical implications for Parkinson disease LV Kalia, SK Kalia, PJ McLean, AM Lozano, AE Lang Annals of neurology 73 (2), 155-169, 2013 | 414 | 2013 |
| Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ... Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014 | 390 | 2014 |
| Disease‐modifying strategies for Parkinson's disease LV Kalia, SK Kalia, AE Lang Movement Disorders 30 (11), 1442-1450, 2015 | 304 | 2015 |
| Low-intensity ultrasound neuromodulation: an overview of mechanisms and emerging human applications A Fomenko, C Neudorfer, RF Dallapiazza, SK Kalia, AM Lozano Brain stimulation 11 (6), 1209-1217, 2018 | 264 | 2018 |
| BAG5 inhibits parkin and enhances dopaminergic neuron degeneration SK Kalia, S Lee, PD Smith, L Liu, SJ Crocker, TE Thorarinsdottir, ... Neuron 44 (6), 931-945, 2004 | 249 | 2004 |
| Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning A Boutet, R Madhavan, GJB Elias, SE Joel, R Gramer, M Ranjan, ... Nature communications 12 (1), 3043, 2021 | 230 | 2021 |
| Outcomes from stereotactic surgery for essential tremor RF Dallapiazza, DJ Lee, P De Vloo, A Fomenko, C Hamani, M Hodaie, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (4), 474-482, 2019 | 209 | 2019 |
| Canadian guideline for Parkinson disease D Grimes, M Fitzpatrick, J Gordon, J Miyasaki, EA Fon, M Schlossmacher, ... Cmaj 191 (36), E989-E1004, 2019 | 170 | 2019 |
| Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5) LV Kalia, SK Kalia, H Chau, AM Lozano, BT Hyman, PJ McLean PloS one 6 (2), e14695, 2011 | 170 | 2011 |
| Deep brain stimulation for Parkinson's disease and other movement disorders SK Kalia, T Sankar, AM Lozano Current opinion in neurology 26 (4), 374-380, 2013 | 163 | 2013 |
| Systematic review of hardware-related complications of deep brain stimulation: do new indications pose an increased risk? O Jitkritsadakul, R Bhidayasiri, SK Kalia, M Hodaie, AM Lozano, A Fasano Brain Stimulation 10 (5), 967-976, 2017 | 160 | 2017 |
| Physiological mechanisms of thalamic ventral intermediate nucleus stimulation for tremor suppression L Milosevic, SK Kalia, M Hodaie, AM Lozano, MR Popovic, WD Hutchison Brain 141 (7), 2142-2155, 2018 | 147 | 2018 |
| Deep brain stimulation for Parkinson’s disease: meta-analysis of results of randomized trials at varying lengths of follow-up A Mansouri, S Taslimi, JH Badhiwala, CD Witiw, F Nassiri, VJJ Odekerken, ... Journal of neurosurgery 128 (4), 1199-1213, 2018 | 133 | 2018 |
| Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein C McKinnon, ML De Snoo, E Gondard, C Neudorfer, H Chau, SG Ngana, ... Acta Neuropathologica Communications 8 (1), 17, 2020 | 122 | 2020 |
| Molecular chaperones as rational drug targets for Parkinson's disease therapeutics S K Kalia, L V Kalia, P J McLean CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2010 | 121 | 2010 |
| α-Synuclein and Lewy pathology in Parkinson's disease LV Kalia, SK Kalia Current opinion in neurology 28 (4), 375-381, 2015 | 119 | 2015 |
| Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease L Milosevic, SK Kalia, M Hodaie, AM Lozano, A Fasano, MR Popovic, ... Brain 141 (1), 177-190, 2018 | 117 | 2018 |
| Deep brain stimulation targets in epilepsy: systematic review and meta‐analysis of anterior and centromedian thalamic nuclei and hippocampus A Vetkas, A Fomenko, J Germann, C Sarica, C Iorio‐Morin, N Samuel, ... Epilepsia 63 (3), 513-524, 2022 | 115 | 2022 |
